Terms: = Uterine cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Prognosis
24 results:
1. Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.
Zhang T; Zhou C; Lv M; Yu J; Cheng S; Cui X; Wan X; Ahmad M; Xu B; Qin J; Meng X; Luo H
Eur J Pharm Sci; 2024 Mar; 194():106706. PubMed ID: 38244809
[TBL] [Abstract] [Full Text] [Related]
2. Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.
Sun Y; Zhou X; Lucas E; Chen L; Zhang H; Chen H; Zhou F
J Pathol Clin Res; 2024 Jan; 10(1):e345. PubMed ID: 37798754
[TBL] [Abstract] [Full Text] [Related]
3. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
4. Identification and verification of a 4-gene signature predicting the overall survival of cervical cancer.
Yuan L; Lu Z; Sun G; Cao D
Medicine (Baltimore); 2022 Oct; 101(42):e31299. PubMed ID: 36281082
[TBL] [Abstract] [Full Text] [Related]
5. Loss of LOXL2 Promotes uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.
Lu X; Xin DE; Du JK; Zou QC; Wu Q; Zhang YS; Deng W; Yue J; Fan XS; Zeng Y; Cheng X; Li X; Hou Z; Mohan M; Zhao TC; Lu X; Chang Z; Xu L; Sun Y; Zu X; Zhang Y; Chinn YE
Cancer Res; 2022 Dec; 82(23):4400-4413. PubMed ID: 36197797
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and prognostic significance of PD-L1, TIM-3 and B7-H3 expression in endometrial serous carcinoma.
Chen H; Molberg K; Carrick K; Niu S; Rivera Colon G; Gwin K; Lewis C; Zheng W; Castrillon DH; Lucas E
Mod Pathol; 2022 Dec; 35(12):1955-1965. PubMed ID: 35804040
[TBL] [Abstract] [Full Text] [Related]
7. Sodium Valproate Modulates the Methylation Status of Lysine Residues 4, 9 and 27 in Histone H3 of HeLa Cells.
Rocha MA; de Campos Vidal B; Mello MLS
Curr Mol Pharmacol; 2023; 16(2):197-210. PubMed ID: 35297358
[TBL] [Abstract] [Full Text] [Related]
8. ARID1A loss-of-function induces CpG island methylator phenotype.
Yamada H; Takeshima H; Fujiki R; Yamashita S; Sekine S; Ando T; Hattori N; Okabe A; Yoshikawa T; Obama K; Katai H; Kaneda A; Ushijima T
Cancer Lett; 2022 Apr; 532():215587. PubMed ID: 35131383
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.
Beilner D; Kuhn C; Kost BP; Vilsmaier T; Vattai A; Kaltofen T; Mahner S; Schmoeckel E; Dannecker C; Jückstock J; Mayr D; Jeschke U; Heidegger HH
Arch Gynecol Obstet; 2021 Nov; 304(5):1307-1314. PubMed ID: 33861372
[TBL] [Abstract] [Full Text] [Related]
10. SIRT1 and gynecological malignancies (Review).
Chen J; Chen H; Pan L
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649834
[TBL] [Abstract] [Full Text] [Related]
11. Role of B7-H4 in the Progression and prognosis of Cervical Inflammation to cancer After Human Papilloma Virus Infection.
Qiu F; Yuan C; Xu J; Zhang J; Chen F; Liu D; Zheng B; Li R; Huang X; Xu J
J Biomed Nanotechnol; 2019 May; 15(5):1043-1051. PubMed ID: 30890234
[TBL] [Abstract] [Full Text] [Related]
12. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Significant Gene Signatures and Prognostic Biomarkers for Patients With Cervical cancer by Integrated Bioinformatic Methods.
Li X; Tian R; Gao H; Yan F; Ying L; Yang Y; Yang P; Gao Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818767455. PubMed ID: 29642758
[TBL] [Abstract] [Full Text] [Related]
14. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract] [Full Text] [Related]
15. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
[TBL] [Abstract] [Full Text] [Related]
16. Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical cancer.
Beyer S; Zhu J; Mayr D; Kuhn C; Schulze S; Hofmann S; Dannecker C; Jeschke U; Kost BP
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28241481
[TBL] [Abstract] [Full Text] [Related]
17. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
[TBL] [Abstract] [Full Text] [Related]
18. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
[TBL] [Abstract] [Full Text] [Related]
19. Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.
Wang Y; Jiang Y; Ikeda J; Tian T; Sato A; Ohtsu H; Morii E
Cancer Med; 2014 Oct; 3(5):1126-35. PubMed ID: 25045085
[TBL] [Abstract] [Full Text] [Related]
20. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract] [Full Text] [Related]
[Next]
